{"Clinical Trial ID": "NCT02279108", "Intervention": ["INTERVENTION 1:", "Indocyanin + Isotope", "Injection of 2.5 milligrams of indocyanin green and 20 MBq of technetium 99 prior to breast surgery", "Indocyanin green: one injection, 2.5 milligrams per patient, intradermal use", "1 injection, 20 MBq techntium99, intradermal use", "INTERVENTION 2:", "Isotope detection alone", "20 MBq intradermal injection of technetium 99 before breast surgery", "1 injection, 20 MBq techntium99, intradermal use"], "Eligibility": ["Incorporation criteria:", "A breast cancer infiltrated by histology (inductive carcinoma, lobular...) or an in-situ carcinoma with a high risk of micro-invasion. (High level with necrosis, radiologically estimated size more than 40mm, or immediate mastectomy...)", "Unifocal or multifocal but in the same quarter", "Size < 5 cm clinically palpable or not", "Axillary Clinically or Ultrasonicly N0", "\u25cf Detection of isotopic sentinel nodes", "In adults", "Informed consent signed by a patient or a legally responsible authority", "Patient enrolled in a social security system", "No surgical contraindications", "- Exclusion criteria:", "Recurrence of mammalian carcinoma", "Previous same side breast reduction", "Previous rumpectomy", "Contraindication to surgery", "Pregnant or lactating patient", "- Refusal to participate"], "Results": ["Performance measures:", "Number of patients with less than two lymph nodes detected", "Number of patients with less than two lymph nodes detected by indocyanin (ICG) + isotope detection only", "Duration: peroperative", "Results 1:", "Title of arm/group: Double detection Indocyanin + Isotope", "Description of the arm/group: 2.5 milligram intradermal injection of indocyanin green and 20 MBq of technetium 99 prior to breast surgery", "Indocyanin green: one injection, 2.5 milligrams per patient, intradermal use", "1 injection, 20 MBq techntium99, intradermal use", "Total number of participants analysed: 50", "Type of measure: Number of participants", "Unit of measure: Participants 22 44.0%", "Results 2:", "Title of the arm/group: Isotope detection alone", "Description of the arm/group: 20 MBq intradermal injection of technetium 99 prior to breast surgery", "1 injection, 20 MBq techntium99, intradermal use", "Total number of participants analysed: 49", "Type of measure: Number of participants", "Unit of measure: Participants 20 40.8%"], "Adverse Events": ["Undesirable Events 1:", "Total: 0/50 (0.00 per cent)", "Adverse Events 2:", "Grand total"]}